Grantham, Mayo, Van Otterloo & Co (GMO)
BRKR icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Bruker BRKR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Buy
296,163
+14,924
+5% +$697K 0.04% 197
2026
Q1 		$10.2M Buy
281,239
+3,473
+1% +$145K 0.03% 241
2025
Q4 		$13.1M Sell
277,766
-192,935
-41% -$8.15M 0.03% 218
2025
Q3 		$15.3M Buy
470,701
+4,394
+0.9% +$157K 0.04% 199
2025
Q2 		$19.2M Buy
466,307
+78,035
+20% +$3.01M 0.06% 183
2025
Q1 		$16.2M Buy
+388,272
New +$20.2M 0.05% 199
2024
Q2 		– Sell
-265,583
Closed -$24.9M – 531
2024
Q1 		$24.9M Buy
265,583
+60,824
+30% +$4.89M 0.09% 160
2023
Q4 		$15M Buy
204,759
+58,946
+40% +$3.78M 0.07% 201
2023
Q3 		$9.08M Buy
145,813
+28,062
+24% +$1.89M 0.04% 268
2023
Q2 		$8.7M Hold
117,751
– – 0.04% 273
2023
Q1 		$9.28M Buy
117,751
+44,255
+60% +$3.19M 0.05% 254
2022
Q4 		$5.02M Sell
73,496
-29,383
-29% -$1.87M 0.03% 333
2022
Q3 		$5.46M Buy
+102,879
New +$6.15M 0.03% 321
2020
Q2 		– Sell
-24,500
Closed -$879K – 756
2020
Q1 		$879K Sell
24,500
-225
-0.9% -$10.4K 0.01% 520
2019
Q4 		$1.26M Sell
24,725
-17,002
-41% -$810K 0.01% 479
2019
Q3 		$1.83M Sell
41,727
-17,100
-29% -$766K 0.01% 446
2019
Q2 		$2.94M Sell
58,827
-17,370
-23% -$732K 0.02% 388
2019
Q1 		$2.93M Sell
76,197
-11,200
-13% -$404K 0.02% 357
2018
Q4 		$2.6M Sell
87,397
-7,500
-8% -$237K 0.02% 248
2018
Q3 		$3.17M Sell
94,897
-7,200
-7% -$237K 0.02% 256
2018
Q2 		$2.96M Buy
102,097
+12,797
+14% +$389K 0.02% 270
2018
Q1 		$2.67M Buy
89,300
+69,900
+360% +$2.27M 0.02% 288
2017
Q4 		$666K Buy
19,400
+8,800
+83% +$288K ﹤0.01% 417
2017
Q3 		$315K Buy
+10,600
New +$305K ﹤0.01% 469

Other funds holding BRKR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BRKR Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Bruker (BRKR) stake by 5.3% in Q2 2026, buying an estimated $697K and bringing the position to 296,163 shares worth $17.8M. The position accounts for 0.04% of the portfolio, ranked #197.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BRKR in Q3 2017 and has held it in 24 quarters since. The position peaked at $24.9M in Q1 2024. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 296,163 shares of Bruker worth $17.8M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 14,924 Bruker shares in Q2 2026, an estimated $697K.
  • Bruker made up 0.04% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #197 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Bruker in Q3 2017 and has held it in 24 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Bruker position peaked at $24.9M in Q1 2024.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.